May 3, 2021
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Attention: Abby Adams
|
Re:
|
Chembio Diagnostics, Inc.
Registration Statement on Form S-3
Filed March 15, 2021
File No. 333-254261
Request for Acceleration
|
Sincerely,
|
|||
Chembio Diagnostics, Inc.
|
|||
By:
|
/s/Neil A. Goldman
|
||
Neil A. Goldman
|
|||
Executive Vice President, Chief Financial Officer
|
cc:
|
Mark L. Johnson, K&L Gates LLP
Bella Zaslavsky, K&L Gates LLP
|